Blood tests to predict immunotherapy response in head and neck cancer

This research study is testing whether a new type of blood test can predict how well immunotherapy will work for people with head and neck cancer. Instead of taking repeated tissue biopsies (which can be uncomfortable and difficult to repeat), researchers want to use blood samples to look for specific markers that show whether your cancer cells will respond to immunotherapy treatment. Early results show this blood test method is promising and may help doctors personalize your treatment plan.

Immunotherapy has become an important first-line treatment for advanced head and neck cancer, but doctors currently have difficulty predicting which patients will benefit most from this medication. Getting updated tissue samples to check treatment markers is challenging and invasive. This study exists to develop a simpler blood test that could dynamically track whether the treatment is likely to work, helping doctors make better, faster treatment decisions.